AzTrials
AzTrials

Spinal Stenosis LumbarNCT04447950

Randomized Control Trial of Quadratus Lumborum Block for Lumbar Spine Decompression and Fusion Surgery

A study testing Type 2/posterior Quadratus Lumborum block in people with Spinal Stenosis Lumbar and Spondylolisthesis, run by Assuta Medical Center at 1 site in Israel.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Lumbar spinal decompression and fusion is a commonly performed procedure fro neural impingement and back pain from a variety of pathologies. The importance of pain control in the postoperative period for spinal surgery has been discussed and proven extensively, with both immediate and delayed reduction in… Read more about this study

Who is it for?
Ages 18 to 80 years
What is being tested?
Type 2/posterior Quadratus Lumborum block
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
100 participants
Where
1 siteIsrael
Study dates
Jun 2020to Aug 2021
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 80 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Men and women at the ages of 18-80 suffering from leg + back pain or neurological claudication.
  • Undergoing an elective 1-3 level lumbar laminectomy \& fusion at Assuta medical center.

Who cannot join

  • Chronic narcotic treatment (more than 3 months)
  • Current active Infection.
  • Underwent any other major operation in the last two months.
  • Known hypersensitivity to local anaesthetic
  • Previous lumbar instrumentation (revision of decompression to decompression with fusion will be included)
  • Non Ambulatory patients

Trial locations and contacts

1 site in 1 country.

Ely Ashkenazy, MD contact

+972-3-7645400

ashkenazy@isc.co.il

Israel1 site
  • The Israeli spine center, Assuta medical center

    Tel Aviv, 69710

    Ely Ashkenazy, MD, +972-3-7645400, ashkenazy@isc.co.il

Other trials in Israel

About this study

Official title: A Randomized, Double Blind, Placebo Controlled Evaluation Trial of the Benefit in Quadratus Lumborum Block as a Postoperative Analgesic Technique for a Lumbar Spine Decompression and Fusion Surgery

Lumbar spinal decompression and fusion is a commonly performed procedure fro neural impingement and back pain from a variety of pathologies. The importance of pain control in the postoperative period for spinal surgery has been discussed and proven extensively, with both immediate and delayed reduction in complications and improved clinical results.

Quadratus lumborum (QL) block was introduced in 2007 and is performed under ultrasound guidance for perioperative pain management in various surgeries.However, the plane for a posterior QL block can be easily reached during open midline spinal surgery.

Read more

The investigators hypothesize that the posterior QL block is an effective analgesic tool for lumbar laminectomy surgery, because in lumbar laminectomy the quadratus lumborum is already exposed and is in direct visual contact. For that reason it is imperative to test the benefits of this procedure.

This is a double blinded randomized control study to assess the results of intra-operative QL block performed for lumbar decompression and fusion.

Read the detailed description

Spinal decompression is a surgical procedure that is performed to alleviate pain caused by pinched nerves (neural impingement). Surgical options for decompressing the lumbar spine vary from minimally invasive disc decompression to open laminectomy and foraminotomy. The lumbar spine decompression and fusion differs from a microdiscectomy in that the incision is longer and there is more muscle stripping. Lumbar spinal decompression is a commonly performed procedure and the conventional open techniques of decompression remain the gold standard of treatment.

During a lumbar decompression back surgery, a small portion of the bone over the nerve root and/or disc material from under the nerve root is removed to give the nerve root more space and provide a better healing environment. A lumbar spine decompression and fusion is typically performed to relieve the lumbar spinal stenosis symptoms. The goal of the surgery is to allow more space for the nerve root, thus reducing pain (and potentially any leg weakness or neurological symptoms) and restoring the patient's ability to participate in everyday activities[1].

Quadratus lumborum (QL) block was introduced in 2007 and is performed for perioperative pain management in various abdominal, pelvic, gynecological and hip procedures in all age groups[2]. Four types of QL block were described, differentiated by the exact location of the anesthetic injection. Type 1/lateral QL block is performed at the lateral border of the QL muscle, type 2/posterior QL block is performed at the medial edge of the QL muscle (at the border or the spine erector muscles and the thoraco-lumbar fascia), type 3/anterior is performed between the QL muscle and the psoas major and type 4 is intramuscular (see figure 1). In the majority of cases, these blocks are performed pre/post operatively under ultrasound guidance. There are sporadic reports of QL block performed for lumbar spinal surgery [3, 4].However, the plane for a type 2 QL block can be easily reached during open midline spinal surgery.

The importance of pain control in the postoperative period for spinal surgery has been discussed and proven extensively, with both immediate and delayed reduction in complications and improved clinical results [5, 6].

The investigators hypothesize that the type 2 QL block is an effective analgesic tool for lumbar laminectomy surgery, because in lumbar laminectomy the quadratus lumborum is already exposed and is in direct visual contact. For that reason it is imperative, in our opinion, to test its benefits of this procedure.

Study's objective:

To test the safety and efficacy of open quadratus lumborum block as an add-on postoperative analgesic technique for lumbar spine decompression and fusion.

Study design:

This is a pilot comparative study, double blind and placebo controlled . Patients scheduled for a lumbar spine decompression and fusion will be divided randomly into two groups of N=50 each. Subjects in both groups will receive an intra-operative exposure of the posterior QL block plane, with injection of long acting local anesthetic for group A and Saline for group B. Both groups will be monitored during their admission in the department for opioid dose administered, reported pain levels (NRS), narcotics side effects (delirium, urinary retention, falls) and general operative complications. Patient pain levels, satisfaction and general complications will be gathered during clinic follow up.

Methods:

Patients arriving to undergo lumbar spine decompression and fusion will be offered to participate in the study. They will receive a thorough explanation about the study and will sign an informed consent form. The division into each group will be done randomly on a one by one basis, by an operating room nurse. The scrubbed nurse will be exposed to the nature of the substance injected for its sterile preparation, however the surgeons will be blinded to it. Patients will be blinded to their study arm until the end of the study. The lumbar laminectomy (open decompression) procedure will be performed as usual:

  • First, the back is approached through a two-inch to five-inch long incision in the midline of the back, and the left and right back muscles (erector spinae) are dissected off the lamina on both sides and at multiple levels.
  • After the spine is approached, the lamina is removed (laminectomy), allowing visualization of the nerve roots.
  • The facet joints, which are directly over the nerve roots, may then be undercut (trimmed) to give the nerve roots more room.
  • Fusion will be performed with pedicular screws and rods and when indicated an interbody device.

Study group A will be given an analgesic injection into the quadratus lumborum, comprising of Marcaine 0.25% with normal saline (for a total of 20 ml per side). Study group B will receive an identical procedure, however with 20 ml normal saline alone per side. Time required to perform the block for both sides will be measured.

The postoperative regime will include a standardized pain protocol as is used in routine practice. all other operative or postoperative procedures are the same for both groups. Data will be collected from nurses and physical therapy as well as discharge notes. A standardized form for obtaining data will be used in clinic follow up at 2-3 weeks and 3-4 months.

Safety data collected:

A subjective report of each patient regarding any adverse events will be collected by the study nurse during their recovery. The surgeon will report at the end of each operation if there were any adverse events and level of difficulty administrating the injection on designated forms.

Being tested
Type 2/posterior Quadratus Lumborum block, Placebo block with Saline
Medical subject headings
Spondylolisthesis

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Type 2/posterior Quadratus Lumborum blockProcedure or surgery

    Injection of local anaesthetic into posterior boundry of Quadratus Lumborum muscle.

  • Placebo block with SalineProcedure or surgery

    Injection of saline into posterior boundary of Quadratus Lumborum muscle.

Study groups in NCT04447950
Study groupRoleWhat they receive
Study groupExperimentalPosterior QL block with 20-40 cc of Bupivocaine in posterior border of Quadratum Lumborum muscle at the end of the operation.
Receives: Procedure: Type 2/posterior Quadratus Lumborum block
Placebo groupPlacebo comparatorPosterior QL block with 40 cc of Saline in posterior border of Quadratum Lumborum muscle at the end of the operation.
Receives: Procedure: Placebo block with Saline

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in the use of post-operative narcotics

    Difference in MME (morphine milligrams equivalent) of inpatient narcotics consumption.

    Measured: Will be reported for each postoperative day during the inpatient stay of the patient to a maximum of 7 days.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted25 Jun 2020
  2. Study startJun 2020 (estimated)
  3. Primary completionMay 2021 (estimated)
  4. Study completionAug 2021 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
2 arms of a RCT.
Masking
Triple blind
Who is masked
Participant, Care provider, Investigator
Enrolment
100 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04447950
Sponsor's protocol ID
0012-20
Status last verified
Jun 2020
First submitted
20 Jun 2020
Last updated
25 Jun 2020
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Benz RJ, Garfin SR. Current techniques of decompression of the lumbar spine. Clin Orthop Relat Res. 2001 Mar;(384):75-81. doi: 10.1097/00003086-200103000-00010.

    PubMed 11249182
  • Elsharkawy H. Quadratus Lumborum Blocks. Adv Anesth. 2017;35(1):145-157. doi: 10.1016/j.aan.2017.07.007. Epub 2017 Oct 3. No abstract available.

    PubMed 29103570
  • Iwamitsu R, Ueshima H, Otake H. RETRACTED: Intermittent bilateral posterior quadratus lumborum block was effective for pain management in lumbar spinal fusion. J Clin Anesth. 2017 Nov;42:16. doi: 10.1016/j.jclinane.2017.08.012. Epub 2017 Aug 6. No abstract available.

    PubMed 28793274
  • Ueshima H, Otake H. RETRACTED: Clinical experience of anterior quadratus lumborum block after lumber surgery. J Clin Anesth. 2017 Feb;37:131. doi: 10.1016/j.jclinane.2016.12.014. Epub 2017 Jan 9. No abstract available.

    PubMed 28235503
  • Yoo JS, Ahn J, Buvanendran A, Singh K. Multimodal analgesia in pain management after spine surgery. J Spine Surg. 2019 Sep;5(Suppl 2):S154-S159. doi: 10.21037/jss.2019.05.04.

    PubMed 31656869
  • Pugely AJ, Martin CT, Gao Y, Mendoza-Lattes S. Causes and risk factors for 30-day unplanned readmissions after lumbar spine surgery. Spine (Phila Pa 1976). 2014 Apr 20;39(9):761-8. doi: 10.1097/BRS.0000000000000270.

    PubMed 24525993
  • McDonnell JG, O'Donnell B, Curley G, Heffernan A, Power C, Laffey JG. The analgesic efficacy of transversus abdominis plane block after abdominal surgery: a prospective randomized controlled trial. Anesth Analg. 2007 Jan;104(1):193-7. doi: 10.1213/01.ane.0000250223.49963.0f.

    PubMed 17179269

Questions about this trial

What is this clinical trial studying?

A study testing Type 2/posterior Quadratus Lumborum block in people with Spinal Stenosis Lumbar and Spondylolisthesis, run by Assuta Medical Center at 1 site in Israel.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 25 Jun 2020. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Israel. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Ely Ashkenazy, MD (+972-3-7645400, ashkenazy@isc.co.il), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in the use of post-operative narcotics (time frame: Will be reported for each postoperative day during the inpatient stay of the patient to a maximum of 7 days.). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT04447950, which also lists 7 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 25 Jun 2020.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in